This Project

is a joint innitiative of


Organisations that provided funds to support the CoviDiab Registry


An international group of leading diabetes researchers are establishing a Global Registry of COVID-19-related diabetes.

This registry is specifically designed to establish the extent and characteristics of new-onset, COVID-19-related diabetes, and to investigate its pathogenesis, management and outcomes. The Registry also collects data about presentations with severe metabolic disturbance in pre-existing diabetes (DKA, hyperosmolarity; severe insulin resistance).

Given the very short history of human contact with COVID-19, this registry will rapidly help us understand how COVID-19 related diabetes develops, its natural history and its best management. Studying COVID-19-related diabetes may also uncover novel mechanisms of disease.

This is the DEMO registry, please click here for the LIVE version